|
Volumn 66, Issue 5, 2009, Pages 447-460
|
Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy
|
Author keywords
Functional dyspepsia (FD); Functional gastrointestinal disorders (FGIDs); Future FGIDs pharmacotherapeutical options; Irritable bowel syndrome (IBS)
|
Indexed keywords
ALOSETRON;
ALUMINUM SALT;
AMINOPENICILLIN;
BENZODIAZEPINE DERIVATIVE;
BUSPIRONE;
CISAPRIDE;
DICYCLOVERINE;
DIPHENOXYLATE;
FAMOTIDINE;
GRANISETRON;
LANSOPRAZOLE;
LIDOCAINE;
LOPERAMIDE;
MACROLIDE;
MAGNESIUM SALT;
MEBEVERINE;
METOCLOPRAMIDE;
OMEPRAZOLE;
ONDANSETRON;
PANTOPRAZOLE;
PRUCALOPRIDE;
RABEPRAZOLE;
RANITIDINE;
SCOPOLAMINE;
SEROTONIN AGONIST;
SEROTONIN UPTAKE INHIBITOR;
STOMACH SECRETION INHIBITOR;
TEGASEROD;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
BACTERIAL FLORA;
DIGESTIVE SYSTEM FUNCTION DISORDER;
DISEASE CLASSIFICATION;
DRUG EFFECT;
DYSPEPSIA;
ELECTROGASTROGRAPHY;
FUNCTIONAL GASTROINTESTINAL DISEASE;
GASTROINTESTINAL DISEASE;
GASTROINTESTINAL MOTILITY;
HUMAN;
IRRITABLE COLON;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
REVIEW;
SOCIAL PSYCHOLOGY;
STOMACH SCINTISCANNING;
SYMPTOMATOLOGY;
ANIMALS;
DRUG DELIVERY SYSTEMS;
DYSPEPSIA;
GASTROINTESTINAL AGENTS;
GASTROINTESTINAL DISEASES;
HUMANS;
IRRITABLE BOWEL SYNDROME;
|
EID: 70350506342
PISSN: 00016837
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (43)
|